Literature DB >> 1828968

Indomethacin modulation of monocyte cytokine release following pelvic irradiation for cancer.

B Petrini1, G Wolk, J Wasserman, I Vedin, O Strannegård, H Blomgren, P L Esposti.   

Abstract

Pelvic irradiation for urogenital cancer reduced monocyte release of tumour necrosis factor alpha (TNF-alpha). Addition of indomethacin to monocyte cultures increased TNF-alpha production after but not before irradiation. E. coli lipopolysaccharide (LPS) increased TNF-alpha release before as well as after radiation therapy and addition of indomethacin to LPS-stimulated monocytes further increased TNF-alpha production following radiotherapy. Spontaneous interleukin-1 (IL-1) release was increased in the cancer patients and was not significantly affected by radiation therapy. LPS increased IL-1 release before as well as after irradiation, but indomethacin did not further change IL-1 secretion. These findings suggest that prostaglandins differentially regulate TNF-alpha and IL-1 release. Administration of cyclo-oxygenase inhibitors during radiation therapy might increase TNF-alpha release in vivo and thereby enhance the host defence against tumours.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1828968     DOI: 10.1016/0277-5379(91)90225-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  2 in total

1.  Cyclooxygenase and lipoxygenase inhibitors as modulators of cancer therapies.

Authors:  B A Teicher; T T Korbut; K Menon; S A Holden; G Ara
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  Consistent inhibition of cyclooxygenase drives macrophages towards the inflammatory phenotype.

Authors:  Yi Rang Na; Yi Na Yoon; Dain Son; Daun Jung; Gyo Jeong Gu; Seung Hyeok Seok
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.